John Valliant
2019
In 2019, John Valliant earned a total compensation of $1.4M as Chief Executive Officer at Fusion Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $136,927 |
---|---|
Option Awards | $835,095 |
Salary | $399,299 |
Other | $28,233 |
Total | $1,399,554 |
Valliant received $835.1K in option awards, accounting for 60% of the total pay in 2019.
Valliant also received $136.9K in non-equity incentive plan, $399.3K in salary and $28.2K in other compensation.
Rankings
In 2019, John Valliant's compensation ranked 7,675th out of 13,971 executives tracked by ExecPay. In other words, Valliant earned more than 45.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,675 | 45th |
Manufacturing | 2,993 | 48th |
Chemicals And Allied Products | 1,125 | 49th |
Drugs | 959 | 49th |
Biological Products, Except Diagnostic Substances | 221 | 43rd |
Valliant's colleagues
We found two more compensation records of executives who worked with John Valliant at Fusion Pharmaceuticals in 2019.